Dual therapy with corticosteroid ablates the beneficial effect of DP2 antagonism in chronic experimental asthma.

MLA

Ullah, Md Ashik, et al. “Dual Therapy with Corticosteroid Ablates the Beneficial Effect of DP2 Antagonism in Chronic Experimental Asthma.” Nature Communications, vol. 15, no. 1, Nov. 2024, p. 10253. EBSCOhost, https://doi.org/10.1038/s41467-024-54670-8.

APA

Ullah, M. A., Rittchen, S., Li, J., Curren, B. F., Namubiru, P., Ahmed, T., Howard, D. R., Rahman, M. M., Sikder, M. A. A., Rashid, R. B., Collinson, N., Lor, M., Smythe, M. L., & Phipps, S. (2024). Dual therapy with corticosteroid ablates the beneficial effect of DP2 antagonism in chronic experimental asthma. Nature Communications, 15(1), 10253. https://doi.org/10.1038/s41467-024-54670-8

Chicago

Ullah, Md Ashik, Sonja Rittchen, Jia Li, Bodie F Curren, Patricia Namubiru, Tufael Ahmed, Daniel R Howard, et al. 2024. “Dual Therapy with Corticosteroid Ablates the Beneficial Effect of DP2 Antagonism in Chronic Experimental Asthma.” Nature Communications 15 (1): 10253. doi:10.1038/s41467-024-54670-8.